Arbele Limited

Arbele is a biotech and biopharmaceutical company that has created proprietary discovery platforms to accelerate the development of multifunctional “first-in-class” immunotherapeutics. It's goal is to rapidly generate more effective, ‘combination' treatments for gastrointestinal cancers, including stomach, pancreas, colon, bile duct and liver, which are currently high mortality cancers with limited treatment options.